Literature DB >> 11299251

Biventricular cardiac dysfunction after acute massive pulmonary embolism in the rat.

D M Sullivan1, J A Watts, J A Kline.   

Abstract

Cardiac dysfunction has been documented in vivo after acute massive pulmonary embolism (AMPE). The present study tests whether intrinsic ventricular dysfunction occurs in rat hearts isolated after AMPE. AMPE was induced in spontaneously breathing ketamine-xylazine-anesthetized rats by thrombus infusion until mean arterial blood pressure (MAP) was approximately 40% of basal measurement. A hypotensive control group underwent controlled blood withdrawal to produce MAP approximately 40% of basal levels. Shams underwent identical surgical and anesthesia preparation but without pulmonary embolization. Hearts were perfused in isovolumetric mode, and simultaneous right ventricular (RV) and left ventricular (LV) pressures were measured. AMPE caused arterial hypotension with hypoxemia (PO(2) = 50 +/- 14 Torr), acidemia (pH = 7.26 +/- 0.11), and high lactate concentration (6.9 +/- 1.7 mM). Starling curves from both ventricles demonstrated that AMPE significantly reduced ex vivo systolic contractile function in the RV (P = 0.031) and LV (P = 0.008) compared with both the hypotensive control and sham hearts. AMPE did not alter coronary flow or compliance in either ventricle. Soluble tumor necrosis factor-alpha decreased in the RV (P = 0.043) and LV (P = 0.005) tissue. These data support the hypothesis that AMPE produces intrinsic biventricular dysfunction and suggest that arterial hypotension is not the principal mechanism of this dysfunction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299251     DOI: 10.1152/jappl.2001.90.5.1648

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

1.  Evaluation of autologous blood clot subsegmental pulmonary thromboembolism in minimally invasive experimental canine model.

Authors:  Min-Hee Kang; Hee-Myung Park
Journal:  Int J Exp Pathol       Date:  2013-10       Impact factor: 1.925

2.  Development and comparison of a minimally-invasive model of autologous clot pulmonary embolism in Sprague-Dawley and Copenhagen rats.

Authors:  Michael S Runyon; Michael A Gellar; Nina Sanapareddy; Jeffrey A Kline; John A Watts
Journal:  Thromb J       Date:  2010-02-11

3.  Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.

Authors:  Hong-Li Xiao; Chun-Sheng Li; Lian-Xing Zhao; Jun Yang; Nan Tong; Le An; Qi-Tong Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-07-22       Impact factor: 3.000

4.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

5.  The effects of low-molecular-weight heparin on lung and pulmonary artery injuries in acute pulmonary embolism rat model via platelet-derived growth factor-β.

Authors:  Bing Zhou; Gaozhong Sun; Fuyang Mei; Heyun Xu
Journal:  Saudi Pharm J       Date:  2017-04-28       Impact factor: 4.330

Review 6.  Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension.

Authors:  Andrei A Karpov; Dariya D Vaulina; Sergey S Smirnov; Olga M Moiseeva; Michael M Galagudza
Journal:  Heliyon       Date:  2022-02-24

7.  The effect of nitric oxide inhalation on heart and pulmonary circulation in rabbits with acute massive pulmonary embolism.

Authors:  Zeming Zhang; Kun Pan; Lu Chen; Yancun Wang
Journal:  Exp Ther Med       Date:  2018-05-11       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.